Physiologically based pharmacokinetic combined BTK occupancy modeling for optimal dosing regimen prediction of acalabrutinib in patients alone, with different CYP3A4 variants, co-administered with CYP3A4 modulators and with hepatic impairment

Xu Lifang, Shuang Yu, Huining Liu, Bowen Yi, Guopeng Wang, Yang Liu